Cell Therapy Peptides & Pools
With the recent success of immunotherapy and cell therapies (cytotherapy) the need for clinical grade peptides & peptide pools has grown rapidly. To meet the requirements for peptides in cancer immunotherapy by adoptive cell transfer or dendritic cell pulsing, JPT has established an enhanced production protocol for tailored cell therapy peptides and peptide pools. We produce all of our clinical peptides and pools such as neo-epitope pools, antigen-spanning peptide pools and peptide libraries according to our stringent Clinical Grade or ISO PLUS policies that even exceed the most current DIN EN ISO 9001:2015 regulations*.

Clinical Peptides & PepMix™ Pools
JPT’s Clinical Peptide product lines Clinical Grade and ISO Plus Peptides & PepMix™ Pools are produced in production environments regulated by an enhanced ISO 9001:2015 quality management system for the stringent product requirements of cell therapy such as adoptive cell therapy and dendritic cell pulsing. The resulting products have been shown to be applicable in various clinical applications*.
> Further information and quote request: Clinical Peptides

*Peptides of Clinical Grade and ISO PLUS specifications are designed, manufactured and tested under a quality system certified to ISO 9001.Peptides and peptide pools are intented for in vitro and research purposes only. Any use beyond this intented use requires the explicit approval of the customer’s legislative and regulatory agencies. The customer is obliged to obtain advice from local regulatory authority and shall be solely responsible to ensure that the products are suitable for customer’s particular use and that intented use will not infringe statutory law. JPT invites its customers to visit, inspect and audit its facilities to verify if peptides or peptide pools produced under Clinical Grade or ISO PLUS conditions are suited for a specific application.
News Highlights
AppNotes
Quality Assurance
All production is performed according to ISO 9001:2015 standards